Y. Wang et al., A novel mutation in the NADH-cytochrome b5 reductase gene of a Chinese patient with recessive congenital methemoglobinemia, BLOOD, 95(10), 2000, pp. 3250-3255
Recessive congenital methemoglobinemia due to nicotinamide adenine dinucleo
tide (NADH)-cytochrome b5 reductase (b5R) deficiency is classified into 2 c
linical types: type 1 (erythrocyte type) and type 2 (generalized type). We
found a Chinese family with type 1 recessive congenital methemoglobinemia,
the patients from which were diagnosed according to clinical symptoms and b
5R enzyme activity in the blood cells. To learn the molecular basis of type
1 recessive congenital methemoglobinemia in this Chinese family, we isolat
ed total RNA from the peripheral leukocytes of the propositus and b5R compl
ementary DNA (cDNA) by reverse transcription-polymerase chain reaction (RT-
PCR). The coding region of the b5R cDNA was analyzed by sequencing the clon
ed PCR products. The results showed that the propositus was homozygous for
a G-A transition at codon 203 in exon 7, changing a cysteine to a tyrosine
(Cys203Tyr), To characterize the mutant enzyme, both glutathione S-transfer
ase (GST)-fused wild-type b5R and GST-fused mutant Cys203Tyr b5R were expre
ssed in Escherichia coli and affinity purified, The results showed that the
catalytic activity of the enzyme was not much affected by this amino acid
substitution, but the mutant enzyme exhibited decreased heat stability and
increased susceptibility to trypsin, These properties of the mutant enzyme
would account for the restricted b5R deficiency and mild clinical manifesta
tions of these type 1 patients. The finding of this novel mutation makes co
don 203 the only position within the b5R gene at which more than 1 mutation
has been found. (C) 2000 by The American Society of Hematology.